
CME Group (CME) Stock Forecast & Price Target
CME Group (CME) Analyst Ratings
Bulls say
CME Group has demonstrated robust growth, as evidenced by a record revenue of $1.7 billion, reflecting a 10% year-over-year increase, driven by strong demand in Clearing & Transaction and Market Data revenue sectors. The company has also shown exceptional performance in attracting new retail traders, adding over 90,000 new accounts, which marks a 56% year-over-year increase and indicates sustained interest in futures trading amidst favorable market conditions. Additionally, CME's strategic expansions, including its stake in S&P Dow Jones Indices and the acquisition of NEX, position it favorably for continued growth in global benchmarks and enhanced capital efficiency offerings, particularly in a rising rate environment.
Bears say
CME Group faces significant risks due to a potential decline in open interest (OI), which could lead to deteriorating market sentiment and negative financial conditions, adversely affecting its stock performance. Regulatory uncertainties, such as increased margin requirements and restrictions on trading practices, may further reduce trading volumes, which are crucial for the company's revenue generation. Additionally, the company's reliance on market volatility and elevated trading volumes, influenced by geopolitical tensions and economic uncertainties, poses a fundamental threat to its financial outlook, suggesting a negative trajectory for future earnings.
This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.
CME Group (CME) Analyst Forecast & Price Prediction
Start investing in CME Group (CME)
Order type
Buy in
Order amount
Est. shares
0 shares